What We're Reading: Congress Leaves on Spring Recess Without Zika Funding Vote
Shopping for Nonemergency Care Leads to Modest Reduction in Spending
Medicare Advantage Plans Have Lower Hospitalizations Than Medicare FFS Plans
Creating Sustainability in Accountable Care
Bariatric Surgery Outperforms Drugs, Lifestyle Interventions in Reversing Diabetes in Study
Oncotype DX Test for Breast Cancer Finds Clinical Acceptance, but Disparity Exists
Healthcare Ranks Higher as an Election Issue for Women, Kaiser Poll Finds
What We're Reading: Valeant Increases Aid-in-Dying Drug Price Ahead of California's New Law
Tight Budgetary Measures Impact Care in Public Mental Health Clinics
Chemotherapy's Lasting Impact on Male Fertility in Childhood Cancer Survivors
Changing Stop Loss Formula Can Drive Interest in Risk-Based Models
ACS Now Has a Guideline for Care of Head and Neck Cancer Survivors
What We're Reading: Moderate Drinking May Have No Health Benefits
Medicare to Fund Diabetes Prevention Programs, Burwell Says
Discharge Timing for Children With Cancer and Neutropenia
Big Gaps in Smartphone Responses to Mental, Physical Health Questions
Duke Study Recommends Against Annual LDCT in a Subset of High-Risk Lung Cancer Patients
Alabama's Governor Pitches Lottery to Salvage Medicaid Managed Care Plan
Today Is Diabetes Alert Day. Are You at Risk?
Importance of Selecting the Appropriate Therapy for Inflammatory Bowel Disease in the Managed Care Environment
Prophylactic Mastectomy: Does It Improve Quality of Life?
Polypharmacy in Older Americans a Cause for Concern
What We're Reading: Obamacare, Not Economy, Drove Insurance Coverage Gains
Physicians Spend $15.4 Billion Each Year on Reporting Quality Measures
Majority of ICUs Have Too Many Infections
Increased Travel Burden Could Reduce Prospect of Radiation Treatment
Fewer Amputations, Hospital Deaths as Treatment Switches for Patients with Critical Limb Ischemia
Anthem Sues Express Scripts Over Drug Prices, Operations Issues
Angelina Jolie's Breast Surgeon to Discuss Hereditary Cancer on Lifetime
NICE Reverses Stand on Abiraterone After Janssen Submits Additional Data